COMPOSITION FOR TREATMENT OF CERVIX CANCER

摘要

A composition for treating cancer is provided to show excellent cancer treating effect compared to treatment by a human papilloma virus(HPV) specific siRNA only or an anti-cancer agent only and prevent side effects caused by a highly concentrated anti-cancer agent by using a lowly concentrated anti-cancer agent. A composition for treating cervix cancer comprises a first active part including an HPV specific siRNA as an effective ingredient and a second active part including a lowly concentrated anti-cancer agent such as cisplatin, heptaplatin, carboplatin or riboplatin, wherein the HPV specific siRNA includes a sequence described as SEQ ID : NOs. 1 or 3 to 14. A method for treating cancer comprises the steps of: (a) administering an effective amount of the HPV specific siRNA at one or two times for 24 hours to a patient; and (b) administering an effective amount of the lowly concentrated anti-cancer agent to the patient for 4-7 days. Further, a concentration of the anti-cancer agent is 0.625 to 160 muM.